Atai Life Sciences Price to Free Cash Flow Ratio 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Atai Life Sciences price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

PE Ratio P/S Ratio Price/Book Ratio Price-FCF Ratio Net Worth

Atai Life Sciences price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$20.6B
Quest Diagnostics (DGX)	$17.4B
DaVita (DVA)	$12.3B
Encompass Health (EHC)	$10.4B
Chemed (CHE)	$8.3B
Elanco Animal Health (ELAN)	$7.2B
RadNet (RDNT)	$5.3B
Option Care Health (OPCH)	$3.9B
Amedisys (AMED)	$3.2B
LifeStance Health (LFST)	$2.9B
Astrana Health (ASTH)	$2.9B
Addus HomeCare (ADUS)	$2.3B
U.S Physical Therapy (USPH)	$1.4B
Pennant (PNTG)	$1.1B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Daxor (DXR)	$45M
MEDIROM Healthcare Technologies (MRM)	$14M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$13M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M